SEC FORM 5

SEC Form 5

FORM 5

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0362
Estimated average burden
hours per response:			1.0

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Form 3 Holdings Reported.

Form 4 Transactions Reported.

1. Name and Address of Reporting Person^*

BROSHY ERAN

(Last)

(First)

(Middle)

C/O VENTIV HEALTH

200 COTTONTAIL LN. VANTAGE COURT N.

(Street)

SOMERSET

08873

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
VENTIV HEALTH INC [ vtiv ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

3. Statement for Issuer's Fiscal Year Ended (Month/Day/Year)
12/31/2002

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)	4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned at end of Issuer's Fiscal Year (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common stock	03/08/2002		A4	20,000	A	$2.6	344,961	D
Common stock	03/13/2002		A4	10,000	A	$2.44	344,961	D
Common stock	12/11/2002		D4	45,000	D	⁽¹⁾	344,961	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)	5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock option (right to buy)	$7.94	05/31/2002		D5		503,938	⁽²⁾	09/27/2009	Common stock	503,938	$0	623,938	D
Stock option (right to buy)	$4	12/02/2002		4A	503,938		⁽²⁾	12/02/2012	Common stock	503,938	$0	623,938	D
Stock option (right to buy)	$1.66	12/11/2002		4A	120,000		⁽³⁾	12/11/2012	Common stock	120,000	$0	623,938	D

Explanation of Responses:

1. On December 11, 2002, the Compensation Committee of the Board of Directors of Ventiv Health, Inc. approved the forgiveness of $500,000 in indebtedness of the reporting person to the Company in exchange for the cancellation of 45,000 shares of common stock of the Company held by the reporting person. Such shares of common stock were purchased by the reporting person during 1999 using the proceeds of such indebtedness.

2. Pursuant to an exchange offer on May 31, 2002, the reporting person surrendered 503,938 options on the completion date and was issued an equivalent number of replacement options on December 2, 2002. The options surrendered by the reporting person were scheduled to vest in four equal portions on the first four anniversaries of their date of issuance, which was September 27, 1999. 50% of the replacement options issued therefore were vested and exercisable upon issuance, 25% will vest and become exercisable on December 11, 2003 and the remaining 25% of such replacement options will vest and become exercisable on December 11, 2004, provided the reporting person continues to be employed by the Company on each such date.

3. The 120,000 options issued to the reporting person on December 11, 2002 will vest and become exercisable in equal installments on the first four anniversaries of the date of issuance provided the reporting person continues to serve as a director on such dates.

	Eran Broshy	08/27/2003
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.